Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: New Zealand Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20142
20152
20163
20171
20181
20201
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akebia Therapeutics2
Amgen2
Eli Lilly and Company2
GlaxoSmithKline2
Bayer1
Boehringer Ingelheim1
Cara Therapeutics, Inc.1
Janssen Research & Development, LLC1
Kyntra Bio1
Lexicon Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic16
Anemia5
Diabetes Mellitus, Type 24
Kidney Diseases4
Kidney Failure, Chronic4
Diabetic Nephropathies2
Heart Diseases2
Hyperparathyroidism, Secondary2
Renal Insufficiency2
Aspergillosis, Allergic Bronchopulmonary1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.